F-18 FDG PET诊断心脏结节病的系统评价与荟萃分析
该研究通过系统评价与荟萃分析评估F-18 FDG PET/CT诊断心脏结节病的效能。纳入17项研究共891例患者,汇总灵敏度0.84、特异度0.83,AUC为0.90。联合心肌灌注显像可改善诊断准确性。
要点
- F-18 FDG PET/CT诊断心脏结节病汇总灵敏度0.84、特异度0.83。
- 汇总LR+为4.9、LR-为0.2、诊断比值比27、AUC 0.90。
- 联合心肌灌注显像可改善F-18 FDG PET/CT的诊断准确性。
核心结论
- F-18 FDG PET或PET/CT诊断心脏结节病具有中等灵敏度和特异度。
- 联合心肌灌注显像可改善F-18 FDG PET或PET/CT对心脏结节病的诊断准确性。
- 目前关于F-18 FDG PET检测心脏结节病的文献仍有限,需要进一步大型多中心研究证实其诊断准确性。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed和EMBASE数据库自最早索引日期至2018年3月31日的文献。
- 纳入评估F-18 FDG PET或PET/CT诊断心脏结节病效能的研究,共17项研究、891例患者。
主要发现
- 汇总灵敏度为0.84(95%CI 0.71-0.91),异质性I2=77.5。
- 汇总特异度为0.83(95%CI 0.74-0.89),异质性I2=80.0。
- 汇总LR+为4.9(95%CI 3.3-7.3),LR-为0.2(95%CI 0.11-0.35)。
- 汇总诊断比值比为27(95%CI 14-55)。
- 分层SROC曲线显示曲线下面积为0.90(95%CI 0.87-0.92)。
关键数值与推荐
- 荟萃回归显示联合心肌灌注显像是异质性的来源。
- 原文未报告具体诊断阈值或判读标准。
临床怎么用
- F-18 FDG PET或PET/CT可作为心脏结节病的诊断工具,联合心肌灌注显像可能提高诊断准确性。
- 解读结果时需考虑中等灵敏度和特异度以及研究间异质性。
局限性
- 文献关于F-18 FDG PET检测心脏结节病仍有限。
- 研究间存在异质性(灵敏度I2=77.5,特异度I2=80.0),联合心肌灌注显像是异质性来源。
- 需要进一步大型多中心研究证实诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of the current study was to investigate the diagnostic performance of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for diagnosis of cardiac sarcoidosis (CS) through a systematic review and meta-analysis. METHODS: The PubMed and EMBASE database, from the earliest available date of indexing through 31 March 31, 2018, were searched for studies evaluating the diagnostic performance of F-18 FDG PET or PET/CT for CS. We determined the sensitivities and specificities across studies, calculated positive and negative likelihood ratios (LR+ and LR-), and constructed summary receiver operating characteristic (SROC) curves. RESULTS: Across 17 studies (891 patients), the pooled sensitivity was 0.84 [95% confidence interval (95% CI) 0.71-0.91] with heterogeneity (I2 = 77.5) and a pooled specificity of 0.83 (95% CI 0.74-0.89) with heterogeneity (I2 = 80.0). Likelihood ratio (LR) syntheses gave an overall LR+ of 4.9 (95% CI 3.3-7.3) and LR- of 0.2 (95% CI 0.11-0.35). The pooled diagnostic odds ratio was 27 (95% CI 14-55). Hierarchical SROC curve indicates that the area under the curve was 0.90 (95% CI 0.87-0.92). Meta-regression showed that combined myocardial perfusion imaging was the source of heterogeneity. CONCLUSION: The current meta-analysis showed the moderate sensitivity and specificity of F-18 FDG PET or PET/CT for diagnosis of CS. The presence of combined myocardial perfusion imaging could improve diagnostic accuracy of F-18 FDG PET or PET/CT for diagnosis of CS. At present, the literature regarding the use of F-18 FDG PET for detection of CS remains limited; thus, further large multicenter studies would be necessary to substantiate the diagnostic accuracy of F-18 FDG PET for diagnosis of CS.
引用
- Kim SJ, Pak K, Kim K, et al. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J Nucl Cardiol. 2019. PMID: 30603894. doi:10.1007/s12350-018-01582-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。